Synergistic role of molecular imaging and genomics in thyroid cancer management: from diagnosis to personalized treatment
Samaneh Ahmadi, Mehdi Hoseini, Mehrnaz Sadat Ravari, Mahboobeh Zarei, Pejman Shahrokhi, Pegah Mousavi · 2026
Read Synergistic role of molecular imaging and genomics in thyroid cancer management: from diagnosis to personalized treatment by Samaneh Ahmadi, Mehdi Hoseini, Mehrnaz Sadat Ravari, Mahboobeh Zarei, Pejman Shahrokhi, Pegah Mousavi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13617707.txt.
Description
Samaneh Ahmadi and co-authors review how molecular imaging and gene profiling together are changing thyroid cancer care. Their 2026 review spans care from first diagnosis to tailored treatment. Radioiodine scans and therapy remain standard for the common forms of this cancer, but some tumors take up iodine poorly.
New tracers and hybrid scanners sharpen detection, especially for aggressive tumors. Gene profiling flags changes in genes such as BRAF, RAS, and RET that guide drug choice. Paired mutations can signal more complex disease and hint at drug combinations. Computer analyses of large tumor datasets add maps of mutations and pathways. The authors see machine learning and wider gene testing as the next steps.
Catalog record
| CREATOR | Samaneh Ahmadi, Mehdi Hoseini, Mehrnaz Sadat Ravari, Mahboobeh Zarei, Pejman Shahrokhi, Pegah Mousavi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |